Cribstone Capital Management, LLC Pfizer Inc Transaction History

Cribstone Capital Management, LLC

$169 Million
Q4 2022

A detailed history of Cribstone Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cribstone Capital Management, LLC holds 17,959 shares of PFE stock, worth $460,648. This represents 0.54% of its overall portfolio holdings.

Number of Shares

17,959

Previous 17,217 4.31%

Holding current value

$460,648

Previous $753,000 22.18%

% of portfolio

0.54%

Previous 0.47%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $30,978 - $40,439	742 Added 4.31%	17,959 $920,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $7,964 - $9,722	182 Added 1.07%	17,217 $753,000
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $23,078 - $27,364	496 Added 3.0%	17,035 $893,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $92,872 - $115,080	-2,030 Reduced 10.93%	16,539 $856,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $202,426 - $300,063	4,899 Added 35.84%	18,569 $1.1 Million
Q3 2021 Nov 18, 2021	SELL	$39.25 - $50.42 $1,727 - $2,218	-44 Reduced 0.32%	13,670 $588,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $3,483 - $3,945	-97 Reduced 0.7%	13,714 $537,000
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $41,728 - $47,061	1,246 Added 9.92%	13,811 $500,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $18,542 - $23,578	554 Added 4.61%	12,565 $463,000
Q3 2020 Nov 17, 2020	SELL	$31.75 - $37.25 $118,776 - $139,352	-3,741 Reduced 23.75%	12,011 $441,000
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $28,222 - $34,237	937 Added 6.32%	15,752 $515,000
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $13,244 - $18,923	490 Added 3.42%	14,815 $484,000
Q4 2019 Jan 08, 2020	SELL	$32.92 - $37.36 $227,345 - $258,008	-6,906 Reduced 32.53%	14,325 $561,000
Q3 2019 Nov 20, 2019	SELL	$32.49 - $42.13 $178,207 - $231,083	-5,485 Reduced 20.53%	21,231 $763,000
Q2 2019 Jul 22, 2019	SELL	$36.98 - $41.52 $28,918 - $32,468	-782 Reduced 2.84%	26,716 $1.16 Million
Q1 2019 Apr 11, 2019	SELL	$37.5 - $41.2 $99,337 - $109,138	-2,649 Reduced 8.79%	27,498 $1.17 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $61,936 - $70,614	-1,610 Reduced 5.07%	30,147 $1.32 Million
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $42,984 - $52,137	1,247 Added 4.09%	31,757 $1.4 Million
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $65,992 - $70,355	2,001 Added 7.02%	30,510 $1.11 Million
Q1 2018 Apr 19, 2018	BUY	$31.91 - $37.02 $18,380 - $21,323	576 Added 2.06%	28,509 $1.01 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $16,630 - $17,645	500 Added 1.82%	27,933 $1.01 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $850,423 - $936,836	27,433	27,433 $979,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.

Account

Cribstone Capital Management, LLC Pfizer Inc Transaction History